Brief: Calithera Biosciences Presents New Preclinical Data For CB-668 At Society For Immunotherapy Of Cancer 2020 Annual Meeting
Nov 9 (Reuters) - Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES PRESENTS NEW PRECLINICAL DATA FOR
CB-668
AT SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2020 ANNUAL
MEETING
Source text for Eikon: ID:nGNX4kfkwS
Further company coverage: CALA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution